Holen Sie sich die Stockscreener-App
8.45
3.30%
0.27
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
Kennedy Capital Management LLC Boosts Holdings in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Analysts Set OptimizeRx Co. (NASDAQ:OPRX) Target Price at $9.06 - MarketBeat
OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment - The Manila Times
Whetstone Capital Advisors LLC Invests $6.56 Million in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Blair William & Co. IL Reduces Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
Short Interest in OptimizeRx Co. (NASDAQ:OPRX) Grows By 22.0% - MarketBeat
OptimizeRx Co. (NASDAQ:OPRX) Sees Significant Increase in Short Interest - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) is favoured by institutional owners who hold 59% of the company - Yahoo Finance
Bank of New York Mellon Corp Has $426,000 Stock Position in OptimizeRx Co. (NASDAQ:OPRX) - Defense World
OptimizeRx Files $75 Million Mixed Shelf - Marketscreener.com
OptimizeRx Corp Files For Mixed Shelf Of Up To $75 MillionSEC Filing - MarketScreener
OptimizeRx Co. (NASDAQ:OPRX) Director James Paul Lang Purchases 321,408 Shares - MarketBeat
Royce & Associates LP Takes Position in OptimizeRx Co. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp (NASDAQ: OPRX): The Metrics That Matter Right Now - Stocks Register
OptimizeRx Co. (NASDAQ:OPRX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
OptimizeRx Corp SEC 10-K Report - TradingView
OptimizeRx director James Lang purchases $2.44 million in common stock By Investing.com - Investing.com South Africa
OptimizeRx director James Lang purchases $2.44 million in common stock - Investing.com
OptimizeRx (OPRX) to Release Quarterly Earnings on Wednesday - MarketBeat
Q1 Earnings Forecast for OptimizeRx Issued By B. Riley - MarketBeat
Head to Head Review: OptimizeRx (NASDAQ:OPRX) & CFN Enterprises (OTCMKTS:CNFN) - Defense World
Why OptimizeRx Corp. (OPRX) Soared Last Week? - Insider Monkey
OptimizeRx Corp. (OPRX) Q4 Earnings and Revenues Beat Estimates - MSN
Roth Capital Predicts OptimizeRx's Q1 Earnings (NASDAQ:OPRX) - MarketBeat
Research Analysts Issue Forecasts for OptimizeRx Q1 Earnings - Defense World
OptimizeRx (NASDAQ:OPRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
OptimizeRx (NASDAQ:OPRX) Upgraded at B. Riley - MarketBeat
OptimizeRx Corp [OPRX] CEO makes an insider purchase of 20,000 shares worth 0.1 million. - Knox Daily
OptimizeRx Corporation (NASDAQ:OPRX) Q4 2024 Earnings Call Transcript - Insider Monkey
OptimizeRx Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OptimizeRx Corp (OPRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Margin Expansion - Investing.com Canada
OptimizeRx Q4 results ‘at odds with muted’ outlook, says Roth MKM - TipRanks
OptimizeRx Clocks Double-Digit Revenue Growth In Q4, Forecasts Sales Of At Least $100 Million - Benzinga
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges By Investing.com - Investing.com South Africa
OPTIMIZERx earnings beat by $0.04, revenue topped estimates - Investing.com
Earnings call transcript: OptimizeRx Q4 2024 sees revenue growth, stock surges - Investing.com UK
OptimizeRx Corp reports results for the quarter ended December 31Earnings Summary - TradingView
OptimizeRx Corporation Provides Earnings Guidance for the Full Year 2025 -March 12, 2025 at 07:30 am EDT - MarketScreener
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results - TradingView
OPTIMIZERX Earnings Results: $OPRX Reports Quarterly Earnings - Quiver Quantitative
ForexTV | Small Business Resources - ForexTV.com
0.05%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):